ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.906,08
-0,49%
S&P 500
5.942,47
1,26%
Dow Jones
42.732,13
0,80%
Euro vs US Dollar
1,03115
-0,01%
Bitcoin
98.107,21
0,00%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. ABVC BioPharma Inc (ABVC)

  7. ABVC BioPharma Inc (ABVC) News

ABVC

ABVC BioPharma (ABVC)

ABVC BioPharma Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ABVC
DatumZeitQuelleÜberschriftSymbolFirma
19/12/202414h30GlobeNewswire Inc.ABVC BioPharma Seeks to Revolutionize Mental Health Treatment With a Safe Prozac Alternative, Boasting a MADRS Score Reduction of -13.21NASDAQ:ABVCABVC BioPharma Inc
11/12/202412h30GlobeNewswire Inc.ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, Totaling $546,000 From Three PartnersNASDAQ:ABVCABVC BioPharma Inc
15/11/202421h31Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ABVCABVC BioPharma Inc
15/11/202421h30Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ABVCABVC BioPharma Inc
15/11/202421h28Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ABVCABVC BioPharma Inc
15/11/202421h26Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ABVCABVC BioPharma Inc
15/11/202401h33Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ABVCABVC BioPharma Inc
14/11/202415h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
14/11/202415h00GlobeNewswire Inc.ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational MilestonesNASDAQ:ABVCABVC BioPharma Inc
14/11/202414h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABVCABVC BioPharma Inc
04/11/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
25/10/202418h21Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ABVCABVC BioPharma Inc
22/10/202414h45GlobeNewswire Inc.ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic PartnersNASDAQ:ABVCABVC BioPharma Inc
18/10/202423h23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
10/09/202422h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
20/08/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
16/08/202422h31Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ABVCABVC BioPharma Inc
16/08/202422h30Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ABVCABVC BioPharma Inc
16/08/202422h30Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ABVCABVC BioPharma Inc
15/08/202413h30GlobeNewswire Inc.ABVC BioPharma, Inc. Reports Strong Q2 2024 Financial Results and Strategic AchievementsNASDAQ:ABVCABVC BioPharma Inc
15/08/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
14/08/202421h18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABVCABVC BioPharma Inc
07/08/202423h15Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ABVCABVC BioPharma Inc
02/08/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ABVCABVC BioPharma Inc
26/07/202422h30Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ABVCABVC BioPharma Inc
23/07/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
12/07/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
12/07/202422h00Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ABVCABVC BioPharma Inc
24/05/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
23/05/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
 Showing the most relevant articles for your search:NASDAQ:ABVC

Kürzlich von Ihnen besucht

NYSE
MRK
Merck
CCOM
US100
US Tech 100
TG
432
Arbor Metals
COIN
AVAXUSD
Avalanche
NASDAQ
NVDA
NVIDIA
TG
D7G
Nel ASA
NASDAQ
AMZN
Amazon.com
NYSE
NKE
Nike
NASDAQ
MSFT
Microsoft
PM
XAUUSD
Gold vs US Dollar
AMEX
XLF
Financial Select Sector
DBI
TDXP
Tec DAX
FX
EURUSD
Euro vs US Dollar
COIN
XRPUSD
Ripple
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten